
50 Dasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of GCA. Rheuma-
tology (Oxford) 2010; 49(8):1594–7. http://rheumatology.oxfordjournals.org/content/49/8/1594.long 863

51 Dasgupta B, Giant Cell Arteritis Guideline Development Group. Concise guidance: diagnosis and 
management of giant cell arteritis. Clin Med (Lond) 2010; 10(4):381–6. https://www.ncbi.nlm.nih.gov/pub-
med/20849016

52 Stephens RS, Brown C. Persistent lower abdominal and groin pain: what is the diagnosis? Am J Med 
2005; 118(4):364–7. http://www.amjmed.com/article/S0002-9343(05)00088-4/abstract

53 Weiner SM, Peter HH. Neuropsychiatric involvement in systemic lupus erythematosus. Part 1: 
clinical presentation and pathogenesis. Med Klin 2002; 97(12):730–7. https://www.ncbi.nlm.nih.gov/pub-
med/12491066

54 Reilly PA, Littlejohn GO. Peripheral arthralgic presentation of fibrositis/fibromyalgia syndrome. J 
Rheum 1992; 19:281–3 https://www.ncbi.nlm.nih.gov/pubmed/1629829

55 Richards SC, Scott DL. Prescribed exercise in people with fibromyalgia: parallel group randomised con-
trolled trial. BMJ 2002; 325:185–9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117444/

56 Busch AJ, Schachter CL, Overend TJ, et al. Exercise for fibromyalgia: a systematic review. J Rheumatol 
2008; 35:1130–44. https://www.ncbi.nlm.nih.gov/pubmed/18464301

57 Goldenberg DL. Multidisciplinary modalities in the treatment of fibromyalgia. J Clin Psychiatry 2008; 69 
Suppl 2:25–9. https://www.ncbi.nlm.nih.gov/pubmed/18537461

58 NICE. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and 
management [CG53]. 2007. https://www.nice.org.uk/Guidance/cg53

59 New Zealand Guidelines Group. New Zealand acute low back pain guide. 2004. http://www.acc.co.nz/
PRD_EXT_CSMP/groups/external_communications/documents/guide/prd_ctrb112930.pdf

60 Schneider M, Vernon H, Ko G, et al. Chiropractic management of fibromyalgia syndrome: a system-
atic review of the literature. J Manipulative Physiol Ther 2009; 32:25–40. https://www.ncbi.nlm.nih.gov/
pubmed/19121462

61 Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the 
fibromyalgia syndrome. Arthritis Rheum 1994; 37:1593–601. https://www.ncbi.nlm.nih.gov/pubmed/7526868

62 Russell IJ, Vaeroy H, Javors M, et al. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/
fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35:550–6. https://www.ncbi.nlm.nih.
gov/pubmed/1374252

63 Wood PB, Schweinhardt P, Jaeger E, et al. Fibromyalgia patients show an abnormal dopamine response 
to pain. Eur J Neurosci 2007; 25:3576–82. https://www.ncbi.nlm.nih.gov/pubmed/17610577

64 Reichrath J, Bens G, Bonowitz A, et al. Treatment recommendations for pyoderma gangrenosum: an 
evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; 
53(2):273–83. https://www.ncbi.nlm.nih.gov/pubmed/16021123

## Chapter 13: Surgery

1 American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the 
use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients 
undergoing elective procedures: an updated report by the American Society of Anesthesiologists Com-
mittee on Standards and Practice Parameters. Anesthesiology 2011; 114(3):495–511. https://www.ncbi.nlm.
nih.gov/pubmed/21307770

2 General Medical Council. Consent: Patients and doctors making decisions together. 2008. http://www.
gmc-uk.org/guidance/ethical_guidance/consent_guidance_index.asp

3 BAPEN. Screening & 'MUST'. 2016. http://www.bapen.org.uk/screening-and-must/must

4 NICE. Anticoagulation—oral [Clinical Knowledge Summaries]. 2015. http://cks.nice.org.uk/anticoagu-
lation-oral#!management

5 NIE. Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma [TA268]. 
2012. https://www.nice.org.uk/guidance/ta268

6 Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic 
melanoma. N Engl J Med 2010; 363(8):711–23. http://www.nejm.org/doi/full/10.1056/NEJMoa1003466

7 NICE. Early and locally advanced breast cancer: Diagnosis and treatment [CG80]. 2009. https://www.
nice.org.uk/guidance/cg80

8 NICE. Advanced breast cancer: Diagnosis and treatment [CG81]. 2009, updated 2014. https://www.
nice.org.uk/guidance/cg81

9 NICE. Obesity: Identification, assessment and management [CG189]. 2014. https://www.nice.org.uk/
guidance/cg189

10 Halpin V. Early cholecystectomy. BMJ Best Practice. http://bestpractice.bmj.com/best-practice/evi-
dence/intervention/0411/0/sr-0411-i1.html

11 NICE. Varicose veins: Diagnosis and management [CG168]. 2013. https://www.nice.org.uk/guidance/
cg168

## Chapter 14: Clinical chemistry

1 NICE. Intravenous fluid therapy in adults in hospital [CG174]. 2013. https://www.nice.org.uk/Guidance/
cg174

2 Levey A, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from 
serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern 
Med 1999; 130:461–70. https://www.ncbi.nlm.nih.gov/pubmed/10075613

3 Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, 
unsteadiness, and attention deficits. Am J Med 2006; 119:71.e1–8. https://www.ncbi.nlm.nih.gov/pub-
med/16431193

4 Robertson GL. Vaptan for the treatment of hyponatraemia. Nat Rev Endocrinol 2011; 7:151–61. http://
www.nature.com/nrendo/journal/v7/n3/full/nrendo.2010.229.html

5 Smellie S. Spurious hypokalaemia. BMJ 2007; 334:693. http://www.bmj.com/content/334/7595/693

6 Thomas J, Doherty SM. HIV infection--a risk factor for osteoporosis. J Acquir Immune Defic Syndr 2003; 
33(3):281–91. https://www.ncbi.nlm.nih.gov/pubmed/12843738